ciprofloxacin has been researched along with camptothecin in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 10 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Busonera, B; Fidecka, S; Giliberti, G; Kedzierska, E; Koziol, AE; La Colla, P; Miroslaw, B; Sanna, G; Stefanska, J; Struga, M; Szulczyk, D | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Abdel-Aziz, M; Abuo-Rahma, Gel-D; Kwon, Y; Park, SE; Sayed, MA | 1 |
| Babkina, IN; Boldyreva, EV; Burakova, EA; Silnikov, VN; Tikunova, NV; Yarinich, LA; Zakharov, BA | 1 |
| Bartůněk, P; Horký, P; Konečná, K; Kuneš, J; Pour, M; Sedlák, D; Vacek, J; Voráčová, M | 1 |
| Cizek, A; Imramovsky, A; Jampilek, J; Kauerova, T; Kollar, P; Michnova, H; Pauk, K; Pospisilova, S; Vinsova, J | 1 |
| Chen, YM; Fu, HY; Gao, Y; Hai, P; Ma, BJ; Xiao, JF; Xu, LL; Yang, XL; Zhang, SB | 1 |
| Kato, M; Takada, S; Takayama, S | 1 |
| Acchini, M; Croera, C; Foti, P; Mineo, E; Neri, MG; Pessina, A; Raimondi, A | 1 |
| Berti, E; Cerri, A; Croera, C; Foti, P; Neri, MG; Pessina, A; Piccirillo, M; Raimondi, A | 1 |
| Fabian, I; Halperin, D; Priel, E; Reuveni, D; Shalit, I | 1 |
| Baracos, VE; Dieleman, LA; Field, CJ; Sawyer, MB; Xue, H | 1 |
| Higashi, T; Igarashi, T; Iwasaki, H; Kamitani, Y; Kodawara, T; Masada, M; Nakamura, T; Negoro, Y; Tsukamoto, H; Watanabe, K; Yano, R | 1 |
16 other study(ies) available for ciprofloxacin and camptothecin
| Article | Year |
|---|---|
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Disubstituted thiourea derivatives and their activity on CNS: synthesis and biological evaluation.
Topics: Animals; Anti-HIV Agents; Anti-Infective Agents; Bacteria; Behavior, Animal; Cell Line, Tumor; Central Nervous System; Chemistry Techniques, Synthetic; Drug Design; Fungi; Humans; Male; Mice; Motor Activity; Thiourea | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Novel N-4-piperazinyl-ciprofloxacin-chalcone hybrids: synthesis, physicochemical properties, anticancer and topoisomerase I and II inhibitory activity.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chalcone; Ciprofloxacin; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Piperazines; Structure-Activity Relationship; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 2013 |
Synthesis and structure-activity relationship of novel 1,4-diazabicyclo[2.2.2]octane derivatives as potent antimicrobial agents.
Topics: Animals; Anti-Bacterial Agents; Bridged Bicyclo Compounds; Cell Line; Chemistry Techniques, Synthetic; Humans; Kinetics; Mice; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Octanes; Pseudomonas aeruginosa; Staphylococcus aureus; Structure-Activity Relationship | 2015 |
Nontoxic combretafuranone analogues with high in vitro antibacterial activity.
Topics: Anti-Bacterial Agents; Antifungal Agents; Apoptosis; Bacteria; Cell Proliferation; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Fungi; Furans; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2018 |
In vitro activity of salicylamide derivatives against vancomycin-resistant enterococci.
Topics: Anti-Bacterial Agents; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Enterococcus faecalis; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Vancomycin; Vancomycin-Resistant Enterococci | 2018 |
Prenylated Indole Diterpene Alkaloids from a Mine-Soil-Derived Tolypocladium sp.
Topics: Anti-Infective Agents; Cell Line, Tumor; Diterpene Alkaloids; Humans; Hypocreales; Indoles; Magnetic Resonance Spectroscopy; Soil Microbiology | 2019 |
Comparison of lesions induced by intra-articular injections of quinolones and compounds damaging cartilage components in rat femoral condyles.
Topics: Administration, Oral; Animals; Bleomycin; Camptothecin; Cartilage, Articular; Chondroitin Lyases; Ciprofloxacin; Collagenases; Cycloheximide; Ethylmaleimide; Etoposide; Fluorescent Dyes; Hydroxyurea; Injections, Intra-Articular; Iodoacetates; Iodoacetic Acid; Irinotecan; Levofloxacin; Male; Ofloxacin; Papain; Rats; Rats, Sprague-Dawley; Rhodamines; Topoisomerase I Inhibitors | 1994 |
Altered DNA-cleavage activity of topoisomerase II from WEHI-3B leukemia cells with specific resistance to ciprofloxacin.
Topics: Animals; Anti-Infective Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Division; Ciprofloxacin; DNA Topoisomerases, Type II; DNA, Neoplasm; Drug Resistance, Neoplasm; Leukemia, Myelomonocytic, Acute; Tumor Cells, Cultured | 2001 |
High sensitivity of human epidermal keratinocytes (HaCaT) to topoisomerase inhibitors.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antineoplastic Agents; Camptothecin; Cell Division; Cell Line; Cell Survival; Ciprofloxacin; DNA Topoisomerases, Type I; Dose-Response Relationship, Drug; Doxorubicin; Enzyme Activation; Enzyme Inhibitors; Humans; Keratinocytes; Macrolides; Topoisomerase I Inhibitors | 2001 |
Quinolones as enhancers of camptothecin-induced cytotoxic and anti-topoisomerase I effects.
Topics: Antineoplastic Agents; Apoptosis; Aza Compounds; Camptothecin; Cell Line, Tumor; Ciprofloxacin; DNA; Fluoroquinolones; Humans; Interleukin-8; Moxifloxacin; Quinolines; Topoisomerase I Inhibitors; Vascular Endothelial Growth Factor A | 2008 |
Prophylactic ciprofloxacin treatment prevented high mortality, and modified systemic and intestinal immune function in tumour-bearing rats receiving dose-intensive CPT-11 chemotherapy.
Topics: Animals; Anti-Infective Agents; Antibiotic Prophylaxis; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma; Ciprofloxacin; Colorectal Neoplasms; Diarrhea; Female; Immunity, Mucosal; Intestinal Mucosa; Irinotecan; Lymphatic Metastasis; Neoplasm Transplantation; Rats; Rats, Inbred F344; Spleen; Survival Analysis | 2009 |
The Inhibitory Effect of Ciprofloxacin on the β-Glucuronidase-mediated Deconjugation of the Irinotecan Metabolite SN-38-G.
Topics: Anti-Bacterial Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Ciprofloxacin; Dose-Response Relationship, Drug; Enterohepatic Circulation; Glucuronidase; Glucuronides; Irinotecan; Time Factors | 2016 |